CHARLES SCHWAB INVESTMENT MANAGEMENT INC - LIVENT CORP ownership

LIVENT CORP's ticker is LTHM and the CUSIP is 53814L108. A total of 415 filers reported holding LIVENT CORP in Q3 2023. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of LIVENT CORP
ValueSharesWeighting
Q3 2023$29,587,301
-31.3%
1,607,132
+2.3%
0.01%
-33.3%
Q2 2023$43,085,535
+32.7%
1,570,745
+5.0%
0.01%
+20.0%
Q1 2023$32,477,547
+9.8%
1,495,283
+0.5%
0.01%0.0%
Q4 2022$29,577,627
-34.2%
1,488,557
+1.4%
0.01%
-37.5%
Q3 2022$44,980,000
+54.7%
1,467,520
+14.5%
0.02%
+60.0%
Q2 2022$29,082,000
-15.2%
1,281,689
-2.6%
0.01%0.0%
Q1 2022$34,311,000
+9.3%
1,316,093
+2.3%
0.01%
+11.1%
Q4 2021$31,380,000
+7.2%
1,287,098
+1.6%
0.01%
-10.0%
Q3 2021$29,281,000
+21.6%
1,267,040
+1.9%
0.01%
+25.0%
Q2 2021$24,083,000
+16.2%
1,243,922
+4.0%
0.01%0.0%
Q1 2021$20,720,000
-7.4%
1,196,252
+0.8%
0.01%
-11.1%
Q4 2020$22,369,000
+116.0%
1,187,268
+2.9%
0.01%
+80.0%
Q3 2020$10,355,000
+50.9%
1,154,352
+3.6%
0.01%
+66.7%
Q2 2020$6,861,000
+32.9%
1,113,727
+13.3%
0.00%0.0%
Q1 2020$5,161,000
-36.2%
982,906
+3.9%
0.00%
-25.0%
Q4 2019$8,088,000
+30.3%
945,871
+2.0%
0.00%0.0%
Q3 2019$6,206,000
-0.7%
927,576
+2.7%
0.00%0.0%
Q2 2019$6,248,000
-42.9%
902,884
+1.4%
0.00%
-42.9%
Q1 2019$10,936,000
+578.0%
890,537
+662.2%
0.01%
+600.0%
Q4 2018$1,613,000116,8370.00%
Other shareholders
LIVENT CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Joho Capital 4,273,080$111,399,00015.90%
1492 Capital Management LLC 318,459$8,302,0004.40%
AFTON CAPITAL MANAGEMENT LLC 65,000$1,695,0003.60%
Lisanti Capital Growth, LLC 683,246$17,812,0002.00%
Leeward Investments, LLC - MA 1,898,404$49,491,0001.96%
SELDON CAPITAL LP 117,554$3,065,0001.80%
Granite Investment Partners, LLC 1,545,930$40,302,0001.37%
Canal Insurance CO 172,300$4,492,0001.23%
Penn Capital Management Company, LLC 483,285$11,316,0001.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 324,040$8,448,0001.05%
View complete list of LIVENT CORP shareholders